Christopher Murray
Chief Tech/Sci/R&D Officer bij BLUEPRINT MEDICINES CORPORATION
Vermogen: 3 M $ op 31-03-2024
Actieve functies van Christopher Murray
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Chief Tech/Sci/R&D Officer | 10-10-2017 | - |
Loopbaan van Christopher Murray
Eerdere bekende functies van Christopher Murray
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ARIAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-12-2013 | 01-05-2017 |
Opleiding van Christopher Murray
| Hope College | Undergraduate Degree |
| The University of Chicago | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BLUEPRINT MEDICINES CORPORATION | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
- Beurs
- Insiders
- Christopher Murray
- Ervaring
